Navigation Links
Malaria Parasite Kills Liver Cells Before Infecting Red Blood Cells

A new study led by Volker Heussler of the Bernhard Nocht Institute for Tropical Medicine in Hamburg, Germany, has found that the malarial //parasite avoids the immune system by killing the liver cell occupied by them.

Till now it was known that after infecting man, malarial parasites head to the liver and then to infect the red blood cells, but it was not known how the parasite avoids the immune system. Heussler's team used a technique called intravital imaging to trace the journey of the parasite from the liver to the red blood cells in mice.

Their study, which is published in the August 4 online edition of the journal Science, could help in the development of drugs designed to halt the parasite before it infects the red blood cells.

Robert Ménard, a Howard Hughes Medical Institute (HHMI) international research scholar, and his postdoctoral fellow, Rogerio Amino, at the Institut Pasteur in Paris have filmed the parasite as it transforms into a structure within the dead liver cells.

“The parasite has evolved this complex structure. The best image to describe it is the Trojan horse, because it both transports the parasites and camouflages them,” said Ménard. “The parasite did not evolve this complex system for nothing. It is probably very important that the parasite not travel free in the liver.”
br>
'"/>




Page: 1

Related medicine news :

1. Malaria strikes Munger tribals
2. Sponging Cattle betters spraying in eradicating Malaria
3. Gene researchers make Malaria-resistant mosquito
4. More Treatment Options For Malaria
5. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
6. Jharkhand reports 13,000 Malaria cases
7. Researchers Discover Protein That Causes Malaria
8. Malarial gene ascertained
9. Artesunate Is Better For Malaria Than Quinine
10. New Strategies For Effective Treatment Of Malaria
11. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
Post Your Comments:
(Date:10/13/2008)...wire/ -- The National Coalition for,Quality Colore...cerns over,the National CT Colonography Study publ...edicine. The evidence must be closely evaluated, a... is not without significant,potential risks. The N...y,remains the "Gold Standard" for colorectal cance...
(Date:10/13/2008)...-USNewswire/ -- The 2008 NCPA Digest,sponsored by...10th Annual,Convention. The Digest has been publis...st comprehensive portrait of the financial state o... calendar year. Last year,s,Digest provided an ins...,drug program had played a leading role in reducin...
(Date:10/13/2008)... after weekly doses up to 3 times recommended amou...-- Existing guidelines for treating vitamin D defi...w and put patients at high risk for bone loss and ...ohns Hopkins Children,s Center looked at 262 child...ldren were vitamin D-deficient, and most of them r...
(Date:10/13/2008)...bs.com and numerous newspaper affiliates have anno.... AtlantaJobs.com is the newest online job board ...kers in the metro Atlanta area. , ...AtlantaJobs.com and numerous newspaper affiliates...s.com is the newest online job board dedicated to...
Breaking Medicine News(10 mins):Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 2Health News:Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health 3Health News:Vitamin D Guidelines Too Low for Cystic Fibrosis Kids 2Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2
...roversial licensing scheme. According to it, the p... will be permitted to describe the ailments they c...meopathic remedies into the area of licensed medic...gned. However, doctors and scientists believe that...
...l Centre have found that a glass of orange juice e...ones than any other citrus juices like lemonade. /...published in the October. 26 issue of the Clinical...phrology, indicates though many people are of the ...
...of hay fever and eczema in the U.K has steadied co...isen sharply.// In the research that has been pub...scientists at the University of Edinburgh have sai...ver in UK have stabilised, after many years of ste...
...e an increased risk of developing lymphoma and leu...auses a lot of joint pain does have the risk of ca...rugs (DMARDs) – including tumor necrosis factor al...logic DMARD may play a role in this. TNF blockers...
Other Medicine News:Health News:Doctors worried about Homeopathic licensing 2Health News:A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay 2Health News:Eczema And Hay Fever Decline In UK While Allergic Reactions On The Rise 2Health News:RA Drugs Not Implicated In Cancer 2
(Date:10/8/2008)...tments for Spinal Cord, Other Nerve,Injuries -, P...rotein that enables,nerve cells to communicate wit...eveloping nervous system. Research into how that p...ve cells may provide a basis for eventual,treatmen...us system,including spinal cord injury., "This e...
(Date:10/8/2008)...ts Expand Testing Using Cellular ... Oct. 8 /- Wild Blueberry antioxidant...ts from a new study,showing Wild Blueberries outpe...e apples, bananas, red grapes and strawberries in ...tivity (CAA) assay. New research,published in the ...
(Date:10/8/2008)...-- Vical Incorporated (Nasdaq: VICL ),today is pr...l data,demonstrating that the company,s Vaxfectin(...protein-based infectious disease vaccines and,pept....D., Ph.D., Vical,s,Senior Vice President of Produ...sday, October 8, at the World Vaccine Congress (Ly...
(Date:10/7/2008)...-- McLaren Health Care and its Great,Lakes Cancer ...g medical,minds to share the latest work underway ...ncer treatments. The October 11th symposium, hoste...Sukamal Saha, M.D., an,award-winning surgical onco...orectal cancer has gained worldwide recognition an...
Breaking Medicine Technology:Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Louis Drapeau Joins Bionovos Board of Directors 3974 1Louis Drapeau Joins Bionovos Board of Directors 3974 2Louis Drapeau Joins Bionovos Board of Directors 3974 3Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 1Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 2Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 3Isolagen Inc Promotes Todd Greenspan to Chief Financial Officer 28CFO 29 14386 4STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 1STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 2STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 3STERIS Corporation Names Michael J Tokich Chief Financial Officer 14384 4VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 1VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 2VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 3VaxGen Common Stock Now Quoted on OTC Bulletin Board 3971 4
...f.--(BUSINESS WIRE)--Jul 6, 2007 - Cobalis Corp.,(...specializing in,anti-allergy medications, today re... III clinical trials for its drug,PreHistin(TM) in...nal allergic rhinitis, commonly known as hay fever...h placebo and,PreHistin-treated patient groups, th...
...pective biomarker trial in non-small cell lung can...tCall/ -- Response,Genetics, Inc. today announced ... the July 1 issue of the Journal of Clinical,Oncol...Excision-Repair Cross-Complementing 1 (ERCC-1) in ... cancer (NSCLC) predicts for,sensitivity to cispla...
Other Medicine Technology:Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 2Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 3Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 4Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 5Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4
...fety and comfort of the practitioner in mind. Our ... glass, the industry standard for radiation shield... optical clarity, visible light transmission, powe...otecting your eyes, it also helps you look your be...
Radiation Protection Goggles fit over glasses and can be used by the whole department! 1.0 mm leaded glass, 1.0 mm leaded glass side shields provide increased scatter radiation protection. Clear viny
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection.
Clip-On Glasses clip onto regular eyewear frames. Plano (nonprescription) only. Will not fit over high-plus or high-minus presciptions, or over glasses with thick frames. Black wire frames. Wt. 63 g.
Medicine Products: